GLP-1s like Ozempic masked our cancer symptoms
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though…
Obesity rates in Britain mean lift capacity limits could be ‘unsafe’ – study shows
Lift capacity signs are based on ‘outdated assumptions of the weight of the average Brit’ – and mean…
GLP-1 plus therapy can reduce heavy drinking
May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
Ozempic users face more stigma than people who don’t lose weight: study
In the Ozempic era, not all pounds lost are met with praise. New research suggests that people may…
Weight-Loss Drugs Like Ozempic May Come With an Unexpected Cost
Glucagon-like peptide-1 (GLP-1) medications are drugs used to treat type 2 diabetes and support weight loss. They mimic…
Novo Nordisk vs. Pfizer: Which Healthcare Giant Is the Better Bet?
Novo Nordisk NVO and Pfizer PFE are both pharmaceutical giants based in Denmark and the United States, respectively, with…
Bread Might Be Making You Gain Weight Even Without Eating More Calories
In a new study, mice strongly preferred foods like bread, rice, and wheat, abandoning their regular diet and…
People judge weight loss more harshly when GLP-1 drugs are involved, study finds
Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
LLY’s Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes Study
Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1…
The ripple effects of GLP-1s
SIOUX FALLS, S.D. (Dakota News Now) – Weight-loss medications are making headlines nationwide, but their impact may be…